Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: Impact on Hospitalizations and Health Care Resource Utilization in a Universal Health Care Setting.
Saved in:
| Title: | Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: Impact on Hospitalizations and Health Care Resource Utilization in a Universal Health Care Setting. |
|---|---|
| Authors: | Råket, Hans Kristian1,2 (AUTHOR) hans.kristian.raaket.pedersen@regionh.dk, Ankarfeldt, Mikkel Zöllner2 (AUTHOR), Wang, Joanna Nan1,2 (AUTHOR), Pressler, Tacjana3,4 (AUTHOR), Jensen-Fangel, Søren5 (AUTHOR), Qvist, Tavs3 (AUTHOR), Faurholt-Jepsen, Daniel3 (AUTHOR), Jimenez-Solem, Espen1,2,6 (AUTHOR), Petersen, Janne2,7 (AUTHOR), Jensen, Camilla Bjørn2 (AUTHOR), Leo-Hansen, Christian (AUTHOR), Bryrup, Thomas (AUTHOR), Mathiesen, Inger Hee Mabuza (AUTHOR), Dahl, Christine Højte (AUTHOR), Olsen, Mette Frahm (AUTHOR), Henriksen, Esben Herborg (AUTHOR), Katzenstein, Terese (AUTHOR), Skov, Marianne (AUTHOR), Nielsen, Bibi Uhre (AUTHOR), Larsen, Karlen Stade Bader (AUTHOR) |
| Source: | Pulmonary Therapy. Jun2025, Vol. 11 Issue 2, p235-247. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
